Salesforce To $225? Plus Mizuho Predicts $135 For VMware

Mizuho cut the price target on Salesforce, Inc. (NYSE: CRM) from $235 to $225. Mizuho analyst Gregg Moskowitz maintained the stock with a Buy rating. Salesforce shares rose 0.9% to $160.06 in pre-market trading.
  • Mizuho cut the price target on Salesforce, Inc. (NYSE:CRM) from $235 to $225. Mizuho analyst Gregg Moskowitz maintained the stock with a Buy rating. Salesforce shares rose 0.9% to $160.06 in pre-market trading.
  • Mizuho cut the price target for VMware, Inc (NYSE:VMW) from $138 to $135. VMware shares rose 0.3% to $115.90 in pre-market trading.
  • UBS slashed the price target on The Children’s Place, Inc. (NASDAQ:PLCE) from $46 to $43. Children’s Place shares fell 3.1% to close at $36.54 on Monday.
  • Baird boosted the price target on AECOM (NYSE:ACM) from $83 to $90. AECOM shares rose 0.2% to $78.36 in pre-market trading.
  • BMO Capital cut the price target for Scholar Rock Holding Corporation (NASDAQ:SRRK) from $43 to $32. Scholar Rock Holding shares rose 1.1% to close at $8.59 on Monday.

Check out this: Amazon Looking To Downsize, Here’s A Look At Recent Price Target Cuts By The Most Accurate Analysts

Total
0
Shares
Related Posts
Read More

Adamis Announces Review Of Strategic Alternatives; May Include Partnership Or Sale Of One Or Both Of The Company’s Commercial Products Symjepi® And Zimhi®, A Merger, Sale, Or Reverse Merger Of The Company, And/or Seeking Additional Financing

SAN DIEGO, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), a specialty biopharmaceutical company primarily focused on developing and commercializing products in various

ADMP